- Montréal, Quebec
Research Centre: Human Health Therapeutics
When Vancouver, B.C.'s Zymeworks Inc. opened its doors in 2003, the biotherapeutics company was determined to address a need in the pharmaceutical and chemical markets that was not being served by the existing approaches to protein simulation and engineering. Committed to developing best-in-class antibody and protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases, Zymeworks set out to create a platform that was commercially relevant and that reflected the most recent advances in protein biochemistry and computing architecture.